Cargando…
Correction: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
Autores principales: | Abdullah, Ammara, Akhand, Saeed Salehin, Paez, Juan Sebastian Paez, Brown, Wells, Pan, Li, Libring, Sarah, Badamy, Michael, Dykuizen, Emily, Solorio, Luis, Andy Tao, W., Wendt, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121469/ https://www.ncbi.nlm.nih.gov/pubmed/36922681 http://dx.doi.org/10.1038/s41388-023-02654-1 |
Ejemplares similares
-
Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
por: Abdullah, Ammara, et al.
Publicado: (2020) -
FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition
por: Brown, Wells S., et al.
Publicado: (2016) -
Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche
por: Shinde, Aparna, et al.
Publicado: (2020) -
Fibronectin-Expressing Mesenchymal Tumor Cells Promote Breast Cancer Metastasis
por: Jun, Brian H., et al.
Publicado: (2020) -
4168 Understanding ECM-Based Drug Resistivity in Breast Cancer
por: Libring, Sarah, et al.
Publicado: (2020)